Comparative clinical profile of mirtazapine and duloxetine in practical clinical settings in Japan: a 4-week open-label, parallel-group study of major depressive disorder

MLA

Nagao K, et al. “Comparative Clinical Profile of Mirtazapine and Duloxetine in Practical Clinical Settings in Japan: A 4-Week Open-Label, Parallel-Group Study of Major Depressive Disorder.” Neuropsychiatric Disease and Treatment, vol. 2013, no. default, June 2013, pp. 781–86. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.2e1ba97dc04e0981a8943b9fdfdbc4&authtype=sso&custid=ns315887.

APA

Nagao K, Kishi T, Moriwaki M, Fujita K, Hirano S, Yamanouchi Y, Funahashi T, & Iwata N. (2013). Comparative clinical profile of mirtazapine and duloxetine in practical clinical settings in Japan: a 4-week open-label, parallel-group study of major depressive disorder. Neuropsychiatric Disease and Treatment, 2013(default), 781–786.

Chicago

Nagao K, Kishi T, Moriwaki M, Fujita K, Hirano S, Yamanouchi Y, Funahashi T, and Iwata N. 2013. “Comparative Clinical Profile of Mirtazapine and Duloxetine in Practical Clinical Settings in Japan: A 4-Week Open-Label, Parallel-Group Study of Major Depressive Disorder.” Neuropsychiatric Disease and Treatment 2013 (default): 781–86. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.2e1ba97dc04e0981a8943b9fdfdbc4&authtype=sso&custid=ns315887.